BSE Live
Jan 15, 15:59Prev. Close
3.97
Open Price
4.06
Bid Price (Qty.)
4.11 (2390)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 11, 15:18Prev. Close
4.15
Open Price
4.40
Bid Price (Qty.)
4.20 (500)
Offer Price (Qty.)
4.25 (2249)
| Profit & Loss account of Jupiter Bioscience (in Rs. Cr.) | Mar 06 | Mar 05 | |
| 12 mths | 12 mths | ||
| INCOME | |||
| Revenue From Operations [Gross] | 91.46 | 80.31 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 91.46 | 80.31 | |
| Total Operating Revenues | 91.46 | 80.31 | |
| Other Income | 0.26 | 0.27 | |
| Total Revenue | 91.72 | 80.58 | |
| EXPENSES | |||
| Cost Of Materials Consumed | 52.64 | 56.18 | |
| Purchase Of Stock-In Trade | 0.00 | 0.00 | |
| Operating And Direct Expenses | 0.39 | 0.29 | |
| Changes In Inventories Of FGWIP And Stock In Trade | -1.51 | -3.30 | |
| Employee Benefit Expenses | 4.17 | 3.48 | |
| Finance Costs | 7.31 | 5.72 | |
| Depreciation And Amortisation Expenses | 11.98 | 9.80 | |
| Other Expenses | -9.54 | -14.34 | |
| Total Expenses | 68.37 | 59.75 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 23.35 | 20.83 | |
| Exceptional Items | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 23.35 | 20.83 | |
| Tax Expenses-Continued Operations | |||
| Current Tax | 5.43 | 3.15 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | |
| Deferred Tax | -0.55 | 0.57 | |
| Other Direct Taxes | 0.09 | 0.00 | |
| Total Tax Expenses | 4.96 | 3.72 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 18.39 | 17.10 | |
| Profit/Loss From Continuing Operations | 18.38 | 14.92 | |
| Profit/Loss For The Period | 18.38 | 14.92 | |
| Minority Interest | 0.00 | 0.00 | |
| Consolidated Profit/Loss After MI And Associates | 18.38 | 14.92 | |
| OTHER ADDITIONAL INFORMATION | |||
| EARNINGS PER SHARE | |||
| Basic EPS (Rs.) | 21.00 | 17.00 | |
| Diluted EPS (Rs.) | 21.00 | 17.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | |||
| Equity Share Dividend | 2.22 | 1.99 | |
| Tax On Dividend | 0.31 | 0.28 |
25.03.2026
25.03.2026
25.03.2026
24.03.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth